Cargando…

Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure

BACKGROUND: Patients with heart failure and an implantable cardioverter‐defibrillator (ICD) for primary prevention are at increased mortality risk after receiving shock therapy. We sought to determine the prognostic significance of ICD therapies, both shock and antitachycardia pacing, delivered for...

Descripción completa

Detalles Bibliográficos
Autores principales: Biton, Yitschak, Daimee, Usama A., Baman, Jayson R., Kutyifa, Valentina, McNitt, Scott, Polonsky, Bronislava, Zareba, Wojciech, Goldenberg, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475071/
https://www.ncbi.nlm.nih.gov/pubmed/30857452
http://dx.doi.org/10.1161/JAHA.118.010346
_version_ 1783412707339272192
author Biton, Yitschak
Daimee, Usama A.
Baman, Jayson R.
Kutyifa, Valentina
McNitt, Scott
Polonsky, Bronislava
Zareba, Wojciech
Goldenberg, Ilan
author_facet Biton, Yitschak
Daimee, Usama A.
Baman, Jayson R.
Kutyifa, Valentina
McNitt, Scott
Polonsky, Bronislava
Zareba, Wojciech
Goldenberg, Ilan
author_sort Biton, Yitschak
collection PubMed
description BACKGROUND: Patients with heart failure and an implantable cardioverter‐defibrillator (ICD) for primary prevention are at increased mortality risk after receiving shock therapy. We sought to determine the prognostic significance of ICD therapies, both shock and antitachycardia pacing, delivered for different ventricular arrhythmia (VA) rates. METHODS AND RESULTS: We evaluated mortality risk among 1790 ICD‐implanted patients from MADIT‐CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). For the first analysis, patients were divided into mutually exclusive groups by the rate of treated VA only: slow VA (<200 beats per minute) and fast VA (≥200 beats per minute or ventricular fibrillation). In a secondary analysis, both the type of ICD therapy and VA rate were used. The reference group was always patients who had no ICD therapy. ICD therapy for fast VA was associated with increased mortality risk (hazard ratio [HR], 2.27; 95% CI, 1.48–3.48; P<0.001). However, mortality risk after ICD therapy for slow VA was similar to the risk related to no ICD therapy (HR, 1.45; 95% CI, 0.86–2.44; P=0.162). Consistently, shocks (HR, 2.96; 95% CI, 1.91–4.60; P<0.001) and antitachycardia pacing (HR, 2.22; 95% CI, 0.96–5.14; P=0.063) for fast VA were both associated with increased mortality risk. Shocks and antitachycardia pacing for slow VA were not significantly associated with increased mortality risk (HR, 1.43 [95% CI, 0.52–3.92; P=0.489]; and HR, 1.43 [95% CI, 0.80–2.56; P=0.232], respectively). CONCLUSIONS: In patients with mild heart failure receiving ICD for primary prevention, mortality is associated with the rate of underlying VA rather than the type of therapy. These findings suggest that fast VA is a marker for increased mortality rather than shock therapy directly contributing to increased risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00180271.
format Online
Article
Text
id pubmed-6475071
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64750712019-04-24 Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure Biton, Yitschak Daimee, Usama A. Baman, Jayson R. Kutyifa, Valentina McNitt, Scott Polonsky, Bronislava Zareba, Wojciech Goldenberg, Ilan J Am Heart Assoc Original Research BACKGROUND: Patients with heart failure and an implantable cardioverter‐defibrillator (ICD) for primary prevention are at increased mortality risk after receiving shock therapy. We sought to determine the prognostic significance of ICD therapies, both shock and antitachycardia pacing, delivered for different ventricular arrhythmia (VA) rates. METHODS AND RESULTS: We evaluated mortality risk among 1790 ICD‐implanted patients from MADIT‐CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). For the first analysis, patients were divided into mutually exclusive groups by the rate of treated VA only: slow VA (<200 beats per minute) and fast VA (≥200 beats per minute or ventricular fibrillation). In a secondary analysis, both the type of ICD therapy and VA rate were used. The reference group was always patients who had no ICD therapy. ICD therapy for fast VA was associated with increased mortality risk (hazard ratio [HR], 2.27; 95% CI, 1.48–3.48; P<0.001). However, mortality risk after ICD therapy for slow VA was similar to the risk related to no ICD therapy (HR, 1.45; 95% CI, 0.86–2.44; P=0.162). Consistently, shocks (HR, 2.96; 95% CI, 1.91–4.60; P<0.001) and antitachycardia pacing (HR, 2.22; 95% CI, 0.96–5.14; P=0.063) for fast VA were both associated with increased mortality risk. Shocks and antitachycardia pacing for slow VA were not significantly associated with increased mortality risk (HR, 1.43 [95% CI, 0.52–3.92; P=0.489]; and HR, 1.43 [95% CI, 0.80–2.56; P=0.232], respectively). CONCLUSIONS: In patients with mild heart failure receiving ICD for primary prevention, mortality is associated with the rate of underlying VA rather than the type of therapy. These findings suggest that fast VA is a marker for increased mortality rather than shock therapy directly contributing to increased risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00180271. John Wiley and Sons Inc. 2019-03-12 /pmc/articles/PMC6475071/ /pubmed/30857452 http://dx.doi.org/10.1161/JAHA.118.010346 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Biton, Yitschak
Daimee, Usama A.
Baman, Jayson R.
Kutyifa, Valentina
McNitt, Scott
Polonsky, Bronislava
Zareba, Wojciech
Goldenberg, Ilan
Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title_full Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title_fullStr Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title_full_unstemmed Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title_short Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure
title_sort prognostic importance of defibrillator‐appropriate shocks and antitachycardia pacing in patients with mild heart failure
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475071/
https://www.ncbi.nlm.nih.gov/pubmed/30857452
http://dx.doi.org/10.1161/JAHA.118.010346
work_keys_str_mv AT bitonyitschak prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT daimeeusamaa prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT bamanjaysonr prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT kutyifavalentina prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT mcnittscott prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT polonskybronislava prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT zarebawojciech prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure
AT goldenbergilan prognosticimportanceofdefibrillatorappropriateshocksandantitachycardiapacinginpatientswithmildheartfailure